Tax Resources PH icon

TAX RESOURCES PH

Tax resources for Filipinos

RMC No. 68-2022: Publishes the April 26, 2022 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt medicines under RA No. 11534 (CREATE Act)

Files
Download this file

Summary

RMC No. 68-2022 publishes the April 26, 2022 Food and Drug Administration letter endorsing updates to the List of VAT-Exempt medicines under RA No. 11534 (CREATE Act).

CollapseExpand

Key points

  1. What the letter covers. The letter comes from FDA OIC-Director General Dr. Oscar G. Gutierrez, Jr. and endorses updates to the VAT-exempt medicines list.
  2. Medicines on the list. The list includes certain medicines prescribed for hypertension, diabetes, high cholesterol, kidney diseases, mental illnesses, tuberculosis, cancer and COVID-19 treatment.

Deadlines and effectivity

  • FDA letter dated April 26, 2022

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.